Not applicableLooking for participantsNCT06994169What this trial is testingGlofitamab in Real LifeWho this might be right forLarge B-cell Lymphoma The Lymphoma Academic Research Organisation 250
Not applicableAvailableNCT03123029What this trial is testingExpanded Access to VenetoclaxWho this might be right forChronic Lymphocytic Leukemia (CLL)Multiple MyelomaAcute Myeloid Leukemia (AML)+4 more AbbVie
Not applicableStudy completedNCT04859920What this trial is testingLiving Conditions of Patients With Diffuse Large B-Cell Lymphoma or Follicular Lymphoma in the Côte d'Or RegionWho this might be right forDiffuse Large Cell Diffuse LymphomaFollicular Lymphoma Centre Hospitalier Universitaire Dijon 157
Testing effectiveness (Phase 2)Study completedNCT00445341What this trial is testingFlavopiridol to Treat Relapsed Mantle Cell Lymphoma or Diffuse Large B-Cell LymphomaWho this might be right forLymphoma National Cancer Institute (NCI) 28
Not applicableStudy completedNCT06031194What this trial is testingPharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell LymphomaWho this might be right forCentral Nervous System LymphomaDiffuse Large B-Cell Lymphoma Ohio State University Comprehensive Cancer Center 20
Large-scale testing (Phase 3)UnknownNCT00499018What this trial is testingDose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell LymphomaWho this might be right forDiffuse Large B-Cell LymphomaIPI≥2 Fondazione Italiana Linfomi - ETS 399
Not applicableStudy completedNCT00256490What this trial is testingEarly Evaluation of the Response of Large B Cell Non Hodgkin's Lymphoma to Chemotherapy by PET/CTWho this might be right forLymphoma, Large-Cell Eric Turcotte 82
Testing effectiveness (Phase 2)WithdrawnNCT03880279What this trial is testingAutologous TAC T Cells Targeting CD19 in R/R Large B-Cell LymphomaWho this might be right forLymphoma, B-Cell Triumvira Immunologics, Inc.
Early research (Phase 1)Study completedNCT00614042What this trial is testingPhase 1/1b Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's LymphomaWho this might be right forChronic Lymphocytic Leukemia (CLL)Non-Hodgkin's Lymphoma (NHL) Aptevo Therapeutics 96
Not applicableActive Not RecruitingNCT07709624What this trial is testingEvaluating the Treatment Outcomes of Tafasitamab in Patients With Relapsed/ Refractory Diffuse Large B-cell Lymphoma: a Real-world Evidence StudyWho this might be right forDLBCL TTY Biopharm 50
Testing effectiveness (Phase 2)UnknownNCT05816746What this trial is testingDecitabine and Anti-PD-1 in R/R DLBCLWho this might be right forDiffuse Large B Cell LymphomaRelapse/RecurrenceExtranodal Extension+1 more Chinese PLA General Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06793410What this trial is testingVaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell TransplantationWho this might be right forRecipients of Allogeneic Stem Cell TransplantationHPV (Human Papillomavirus)-AssociatedAcute Myeloid Leukaemia+2 more Vastra Gotaland Region 100
Early research (Phase 1)UnknownNCT05453669What this trial is testingClinical Study of the Efficacy of CD19-CAR-DNT Cells in the Treatment of Relapsed/Refractory B-cell NHLWho this might be right forB-cell Non-Hodgkin's Lymphoma Second Affiliated Hospital, Zhejiang University, School of Medicine 12
Early research (Phase 1)Active Not RecruitingNCT01695941What this trial is testingAlisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin LymphomaWho this might be right forRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Mantle Cell LymphomaRefractory B-Cell Non-Hodgkin Lymphoma+1 more National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Study completedNCT01987505What this trial is testingMabRella Study: A Study to Evaluate the Safety of Switching From Intravenous to Subcutaneous Administration of Rituximab During First-Line Treatment for LymphomaWho this might be right forLymphoma, Non Hodgkin Hoffmann-La Roche 140
Testing effectiveness (Phase 2)UnknownNCT02792491What this trial is testingPhase II Prospective Trial of Addition of Rituximab to Reduced Dose CHOP Chemotherapy in DLBC L Patients Aged 65 Years and OverWho this might be right forDiffuse Large B-cell Lymphoma Pusan National University Hospital 57
Testing effectiveness (Phase 2)Study completedNCT01610180What this trial is testingEltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)Who this might be right forPurpura, Thrombocytopenic, IdiopathicAutoimmune Thrombocytopenic PurpuraAutoimmune Thrombocytopenia+2 more Fondazione Progetto Ematologia 18
Large-scale testing (Phase 3)Looking for participantsNCT07479797What this trial is testingStudy Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line TherapyWho this might be right forRelapsed or Refractory Large B-cell Lymphoma Kite, A Gilead Company 550
Early research (Phase 1)Active Not RecruitingNCT05618327What this trial is testingPhase I Clinical Study of JS203 in Patients With Relapsed/Refractory B-cell Non-Hodgkin's LymphomaWho this might be right forRelapsed/Refractory B-cell Non-Hodgkin's Lymphoma Shanghai Junshi Bioscience Co., Ltd. 104
Testing effectiveness (Phase 2)Looking for participantsNCT06534762What this trial is testingMilaberon in Advanced Solid Tumors: an Open, Multicenter Clinical StudyWho this might be right forNSCLCSCLCColorectal Cancer+4 more Zhejiang Provincial People's Hospital 260